Lipophilicity analysis is a foundational study in modern drug discovery because it directly influences solubility, membrane permeability, nonspecific binding, metabolic behavior, and overall developability. For discovery teams advancing hits, leads, peptides, or beyond-Rule-of-5 molecules, accurate determination of LogP and LogD is essential for making the right chemistry decisions early. BOC Sciences provides comprehensive lipophilicity analysis services using fit-for-purpose experimental strategies for neutral, ionizable, and structurally complex compounds. Our workflows help clients understand pH-dependent partitioning behavior, rank analog series more confidently, connect lipophilicity with permeability and solubility outcomes, and reduce optimization risk across hit evaluation, lead selection, and candidate profiling.
We provide robust lipophilicity measurement strategies for drug-like molecules and discovery compounds, generating data that can be integrated directly into lead optimization workflows.
Because many drug candidates are ionizable, we evaluate lipophilicity across biologically meaningful pH conditions and connect the results with broader ADMET prediction strategies.
Our studies are designed to do more than report a single value. We place lipophilicity data in context with solubility analysis and membrane transport behavior to reveal the true liabilities and opportunities within a compound series.
BOC Sciences supports structurally diverse molecules, from conventional small molecules to difficult chemotypes requiring expanded physicochemical prediction and experimental confirmation strategies.
BOC Sciences helps drug discovery teams define the right lipophilicity window, compare analogs confidently, and reduce property-driven attrition.
We employ classical biphasic partitioning approaches for direct measurement of compound distribution between aqueous and organic phases, generating dependable LogP or LogD values for discovery-stage decision making.
For faster comparative analysis across analog sets, we use chromatographic retention-based approaches that support efficient ranking, higher throughput, and practical profiling of medicinal chemistry series.
Sensitive LC-MS workflows enable accurate quantitation in each phase, making the platform especially useful for compounds available at limited amounts or exhibiting complex UV behavior.
Carefully selected buffer systems and controlled pH conditions allow us to characterize distribution behavior under assay environments that are relevant to ionization state and intended biological application.
We interpret lipophilicity results together with partition coefficient and transport-related data to give clients a more actionable view of compound behavior than isolated measurements alone.
When standard conditions are not ideal, we develop tailored measurement and analytical strategies that accommodate unusual scaffolds, limited sample availability, or complex phase behavior.
BOC Sciences supports lipophilicity analysis for a broad range of discovery and development-stage compounds. We work with conventional small molecules as well as structurally challenging modalities that require careful interpretation of partitioning behavior, ionization effects, and assay compatibility.
Share your compound list, assay objective, and preferred pH conditions. Our scientists will design a practical lipophilicity analysis plan aligned with your discovery goals and data interpretation needs.
We assess molecular structure, expected ionization characteristics, sample availability, and project goals to determine the most suitable lipophilicity measurement strategy and analytical workflow.
Our team selects phase systems, pH conditions, quantitation methods, and equilibration parameters to generate reproducible partitioning data for the target compounds or analog set.
We perform the assay, quantify compound levels in the relevant phases, verify data quality, and analyze trends across pH points or structural modifications where required.
Final reports provide LogP and/or LogD results, experimental context, and practical interpretation that supports compound prioritization, property balancing, and next-step decision making.
Many discovery programs struggle because lipophilicity is discussed as a single number, even when the chemistry clearly indicates strong pH dependence. BOC Sciences helps clients distinguish intrinsic partitioning from observed distribution behavior, ensuring that neutral compounds, ionizable analogs, and buffer-sensitive molecules are interpreted with the correct descriptor and the right scientific context.
Excessive lipophilicity may improve membrane affinity but often introduces major liabilities, including poor aqueous solubility, increased nonspecific binding, and harder downstream development. Our analysis identifies where a compound series is drifting outside a productive property window and supports more balanced optimization across absorption potential and formulation feasibility.
Acids, bases, zwitterions, and advanced chemotypes can behave unpredictably in standard lipophilicity assays. We address this by adjusting experimental design, phase selection, pH strategy, and analytical detection so that the resulting data remain useful for molecules that are not well served by simplified screening assumptions.
A lipophilicity result has limited value if it does not guide chemistry decisions. We contextualize each dataset to help teams compare analog series, interpret substituent effects, understand liability trends, and prioritize compounds for downstream ADME testing or broader property profiling.
Collaborate with BOC Sciences to generate reliable LogP and LogD data, clarify pH-dependent behavior, and guide compound design with stronger physicochemical insight.
We do not stop at reporting values. Our scientists interpret lipophilicity results in the context of ionization, compound class, and downstream property tradeoffs.
From classical partitioning methods to chromatographic screening and sensitive LC-MS quantitation, we select practical approaches that fit your compound and project stage.
We have experience working with ionizable, low-solubility, and structurally complex molecules that often require more thoughtful assay design and data interpretation.
Lipophilicity data can be linked naturally with permeability and partition coefficient studies to support more informed compound progression decisions.
Client Needs: A discovery team working on a kinase-focused heteroaryl amine series needed to understand why several potent analogs showed inconsistent property behavior despite minor substituent changes around a tertiary amine-containing core.
Challenges: The compounds displayed similar calculated cLogP values, yet their experimental behavior suggested meaningful pH-dependent differences that were affecting selection decisions during hit-to-lead progression.
Solution: BOC Sciences designed a comparative lipophilicity study using direct experimental determination across multiple buffered conditions, combined with analytical quantitation of phase distribution. We mapped LogD shifts across the analog set and interpreted the results against structural ionization features and substituent placement.
Outcome: The study revealed that the series contained two distinct property clusters that were not obvious from calculated estimates alone. The client used the data to deprioritize over-lipophilic analogs and refine the next chemistry cycle around more balanced candidates.
Client Needs: A partner developing a macrocyclic scaffold with constrained aromatic and polar regions needed experimental lipophilicity information to compare scaffold edits intended to improve passive permeability without sacrificing tractable physicochemical behavior.
Challenges: Standard assumptions did not translate well to the molecular architecture, and the client needed a practical way to compare a small panel of structurally related molecules that showed nonintuitive partitioning patterns.
Solution: We established a customized chromatographic lipophilicity screening workflow supported by confirmatory quantitation for representative members of the set. Our team correlated retention-driven trends with direct distribution data and highlighted how subtle ring and side-chain changes altered effective lipophilicity.
Outcome: The client obtained a clearer structure-property map for the scaffold family and identified which modifications improved balance rather than simply increasing hydrophobicity. The results accelerated analog prioritization for follow-up permeability work.
Client Needs: An oncology research group evaluating ionizable small-molecule leads with a fused bicyclic core and basic side chain required experimentally verified LogD values near physiological pH to interpret inconsistent exposure-related trends across the project.
Challenges: Calculated models suggested a narrow lipophilicity range, but the compounds differed notably in aqueous behavior and likely nonspecific partitioning, creating uncertainty in lead nomination discussions.
Solution: BOC Sciences performed a focused pH-dependent lipophilicity study with matched buffer conditions and sensitive phase quantitation, then interpreted the results together with the series' structural ionization features and companion property information.
Outcome: The analysis showed that apparent similarity in predicted values masked meaningful experimental separation at physiologically relevant pH. This allowed the client to select compounds with more favorable balance for continued optimization and reduced the risk of advancing misleadingly ranked leads.
logP and logD are two of the most widely used parameters in lipophilicity analysis, but they describe different aspects of compound behavior. logP refers to the partition coefficient of the neutral form of a compound between octanol and water, making it most suitable for non-ionizable or neutral molecules. logD, by contrast, is measured at a specific pH and reflects the distribution of all species present, including ionized and non-ionized forms. For drug development projects, this distinction is highly important because many small molecules are ionizable, and their apparent lipophilicity can shift significantly depending on pH. Understanding both parameters helps researchers interpret compound behavior more accurately and choose the right property assessment strategy.
Lipophilicity analysis is a critical part of drug development because it strongly influences how a compound behaves across aqueous and lipid environments, which in turn affects solubility, membrane permeability, nonspecific binding, and overall developability. If lipophilicity is too high, compounds may show poor aqueous behavior and increased assay complexity; if it is too low, membrane transport and balanced performance may become limiting. For professional drug development clients, early evaluation of lipophilicity helps prioritize better candidates, reduce downstream optimization burden, and support more rational lead selection. At BOC Sciences, we help clients assess lipophilicity as part of a broader physicochemical profiling strategy to support informed discovery decisions.
Although logP and logD are both used to describe lipophilicity, they are not interchangeable in practical drug discovery. LogP reflects the partitioning of the neutral form of a compound between octanol and water, while logD reflects distribution at a defined pH and includes the contribution of ionized species. This distinction is especially important for acidic, basic, or amphoteric molecules, where ionization can significantly change real-world behavior. For development teams working with ionizable compounds, logD often provides more actionable insight than logP alone and is more useful for understanding performance under biologically relevant conditions.
Excessive lipophilicity can create multiple challenges during drug development. Highly lipophilic compounds often show reduced aqueous solubility, greater nonspecific interactions, increased binding to hydrophobic surfaces, and less balanced physicochemical performance overall. These issues can complicate compound ranking, reduce confidence in screening data, and make subsequent optimization more difficult. Rather than viewing higher lipophilicity as automatically beneficial, experienced teams usually treat it as a parameter that must be carefully controlled within a useful range. BOC Sciences supports clients with lipophilicity-focused testing and interpretation to help identify risks early and improve the efficiency of lead progression.
Lipophilicity optimization is usually about achieving balance rather than simply lowering or increasing a number. Common strategies include reducing unnecessary hydrophobic fragments, introducing appropriate polar functionality, repositioning ionizable groups, and improving the overall relationship between structure and physicochemical behavior. In many projects, small structural changes can produce meaningful shifts in lipophilicity and change how a compound performs across multiple assays. Because calculated values alone may not fully predict real compound behavior, experimental confirmation is often essential. BOC Sciences can support this process with integrated lipophilicity evaluation services that help clients connect structural modification with practical development outcomes.
BOC Sciences helped us move beyond estimated values and understand how our series really behaved across pH conditions. Their interpretation was highly practical for medicinal chemistry decision making.
— Dr. Martin H., Senior Scientist, Small Molecule Discovery
The team handled a difficult set of low-solubility compounds with excellent method discipline. The data quality gave us confidence to redesign our analog strategy instead of relying on assumptions.
— Laura T., Director, Discovery Chemistry
What stood out most was their ability to explain LogP and LogD in a way that directly supported our project. The final dataset made our permeability and solubility trends much easier to interpret.
— Dr. Chen W., Principal Investigator, Translational Research
We brought them an atypical scaffold that did not fit standard property rules well. Their custom approach to lipophilicity analysis gave us the comparative insight we needed for next-round compound selection.
— James R., Project Leader, Medicinal Chemistry
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.
